WS #13346
Holding: newest synthesis is 110d 1h old
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.
Vertex Pharmaceuticals earnings beat
Vertex raises FY2026 sales guidance and beats Q2 estimates, signaling strength in biotech.